Good morning, everyone. My name is Ian Mortimer, I'm the President and CEO of Xenon Pharmaceuticals, and I will be moderating today's session. Thank you for joining us on this investor webinar focused ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback